Zealand Pharma A/S (ZLDPF) Q4 2025 Earnings Call Transcript

SA Transcripts158.49K FollowersFollow5ShareSaveCommentsPlay Earnings CallPlay Earnings Call Zealand Pharma A/S (ZLDPF) Q4 2025 Earnings Call February 19, 2026 8:00 AM EST Company Participants Adam Lange - Vice President of Investor RelationsAdam Steensberg - President & CEODavid Kendall - Executive VP, Chief Medical Officer & Head of R&DHenriette Wennicke - EVP & CFO Conference Call Participants Hakon Hemme Jørgensen - Danske Bank A/S, Research DivisionRajan Sharma - Goldman Sachs Group, Inc., Research DivisionKirsty Ross-Stewart - BNP Paribas, Research DivisionTsan-Yu Hsieh - William Blair & Company L.L.C., Research DivisionYihan Li - Barclays Bank PLC, Research DivisionXian Deng - UBS Investment Bank, Research DivisionJennifer JiaKerry Holford - Joh. Berenberg, Gossler & Co. KG, Research DivisionSuzanne van Voorthuizen - Kempen & Co. N.V., Research Division Presentation Operator Good day, and thank you for standing by. Welcome to the Zealand Pharma Results Full Year 2025 Conference Call. [Operator Instructions] Please be advised that, today's conference is being recorded. I would now like to hand the conference over to your speaker today, Adam Lange, Vice President, Investor Relations. Please go ahead. Adam LangeVice President of Investor Relations Thank you, operator, and thank you to everyone for joining us today to discuss Zealand Pharma's results for the full year 2025. The related company announcement is available on our website at zealandpharma.com. As outlined on Slide 2, I would like to remind listeners that during today's call, we will be making forward-looking statements that are subject to risks and uncertainties. Turning to Slide 3 and today's agenda. I have with me on the call the following members of Zealand Pharma's management team: Adam Steensberg, President and Chief Executive Officer; Henriette Wennicke, Chief Financial Officer; and David Kendall, Chief Medical Officer. All speakers will be available for the Q&A session. Turning to Slide 4. I will now hand the call over to Adam Steensberg, President